TrovaGene Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
259.20
280.20
312.80
381.10
505.40
378.30
Cost of Goods Sold (COGS) incl. D&A
-
250.30
629.20
1,730.50
1,811.40
965.50
Gross Income
-
29.90
316.40
1,349.40
1,306.00
587.20
SG&A Expense
10,819.30
14,975.10
24,957.30
38,005.70
22,115.50
15,801.60
EBIT
10,690.50
14,945.20
25,273.70
39,355.20
23,421.60
16,388.70
Unusual Expense
1,084.10
1,425.90
726.40
1,134.70
429.00
29.60
Non Operating Income/Expense
22.90
24.80
2.80
392.30
170.10
236.80
Interest Expense
17.00
843.30
1,525.50
1,375.50
1,033.90
25.40
Pretax Income
11,810.90
14,325.50
27,471.10
39,203.70
24,906.70
16,461.20
Consolidated Net Income
11,810.90
14,325.50
27,471.10
39,203.70
24,906.70
16,461.20
Net Income
11,810.90
14,325.50
27,471.10
39,203.70
24,906.70
16,461.20
Net Income After Extraordinaries
11,810.90
14,325.50
27,471.10
39,203.70
24,906.70
16,461.20
Net Income Available to Common
11,840.80
14,348.50
27,495.30
39,228.00
24,931.00
19,255
EPS (Basic)
8.37
10.55
14.52
16.44
8.64
8.26
Basic Shares Outstanding
1,414.90
1,575.40
2,183.50
2,514.60
2,890.00
2,330.20
EPS (Diluted)
8.37
10.55
14.47
16.47
8.63
8.26
Diluted Shares Outstanding
1,414.90
1,589.30
2,204.30
2,523.40
2,890.00
2,330.20
EBITDA
10,560.00
14,710.40
24,894.90
38,285.60
22,367.60
15,652.60
Non-Operating Interest Income
3.70
12.20
57.30
-
147.90
219.40
Preferred Dividends
29.80
23.00
24.20
24.20
24.20
2,793.80
About TrovaGene
View Profile
